Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment

被引:101
作者
Young, Ryan M. [1 ]
Phelan, Mes D. [1 ]
Wilson, Wyndham H. [1 ]
Staudt, Louis M. [1 ]
机构
[1] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
关键词
B-cell receptor; cancer; lymphoma; signal transduction; CHRONIC LYMPHOCYTIC-LEUKEMIA; NF-KAPPA-B; BRUTON TYROSINE KINASE; NON-HODGKIN-LYMPHOMA; HUMAN FOLLICULAR LYMPHOMA; L265P SOMATIC MUTATION; LYN-DEFICIENT MICE; GERMINAL CENTER; GENE-EXPRESSION; ACALABRUTINIB ACP-196;
D O I
10.1111/imr.12792
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Signals emanating from the B-cell receptor (BCR) promote proliferation and survival in diverse forms of B-cell lymphoma. Precision medicine strategies targeting the BCR pathway have been generally effective in treating lymphoma, but often fail to produce durable responses in diffuse large B-cell lymphoma (DLBCL), a common and aggressive cancer. New insights into DLBCL biology garnered from genomic analyses and functional proteogenomic studies have identified novel modes of BCR signaling in this disease. Herein, we describe the distinct roles of antigen-dependent and antigen-independent BCR signaling in different subtypes of DLBCL. We highlight mechanisms by which the BCR cooperates with TLR9 and mutant isoforms of MYD88 to drive sustained NF-kappa B activity in the activated B-cell-like (ABC) subtype of DLBCL. Finally, we discuss progress in detecting and targeting oncogenic BCR signaling to improve the survival of patients with lymphoma.
引用
收藏
页码:190 / 213
页数:24
相关论文
共 200 条
[51]   Ibrutinib Resistance in Chronic Lymphocytic Leukemia [J].
Furman, Richard R. ;
Cheng, Shuhua ;
Lu, Pin ;
Setty, Menu ;
Perez, Alexendar R. ;
Guo, Ailin ;
Racchumi, Joelle ;
Xu, Guozhou ;
Wu, Hao ;
Ma, Jiao ;
Steggerda, Susanne M. ;
Coleman, Morton ;
Leslie, Christina ;
Wang, Y. Lynn .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (24) :2352-2354
[52]   Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib [J].
Ghez, David ;
Calleja, Anne ;
Protin, Caroline ;
Baron, Marine ;
Ledoux, Marie-Pierre ;
Damaj, Gandhi ;
Dupont, Mathieu ;
Dreyfus, Brigitte ;
Ferrant, Emmanuelle ;
Herbaux, Charles ;
Laribi, Kamel ;
Le Calloch, Ronan ;
Malphettes, Marion ;
Paul, Franciane ;
Souchet, Laetitia ;
Truchan-Graczyk, Malgorzata ;
Delavigne, Karen ;
Dartigeas, Caroline ;
Ysebaert, Loic .
BLOOD, 2018, 131 (17) :1955-1959
[53]   Systematic review:: regression of lymphoproliferative disorders after treatment for hepatitis C infection [J].
Gisbert, JP ;
García-Buey, L ;
Pajares, JM ;
Moreno-Otero, R .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (06) :653-662
[54]   Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells [J].
Gobessi, S. ;
Laurenti, L. ;
Longo, P. G. ;
Carsetti, L. ;
Berno, V. ;
Sica, S. ;
Leone, G. ;
Efremov, D. G. .
LEUKEMIA, 2009, 23 (04) :686-697
[55]   BREAKDOWN OF SELF-TOLERANCE IN ANERGIC LYMPHOCYTES-B [J].
GOODNOW, CC ;
BRINK, R ;
ADAMS, E .
NATURE, 1991, 352 (6335) :532-536
[56]   Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification [J].
Gorre, ME ;
Mohammed, M ;
Ellwood, K ;
Hsu, N ;
Paquette, R ;
Rao, PN ;
Sawyers, CL .
SCIENCE, 2001, 293 (5531) :876-880
[57]   High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells [J].
Griner, Lesley A. Mathews ;
Guha, Rajarshi ;
Shinn, Paul ;
Young, Ryan M. ;
Keller, Jonathan M. ;
Liu, Dongbo ;
Goldlust, Ian S. ;
Yasgar, Adam ;
McKnight, Crystal ;
Boxer, Matthew B. ;
Duveau, Damien Y. ;
Jiang, Jian-Kang ;
Michael, Sam ;
Mierzwa, Tim ;
Huang, Wenwei ;
Walsh, Martin J. ;
Mott, Bryan T. ;
Patela, Paresma ;
Leister, William ;
Maloney, David J. ;
Leclair, Christopher A. ;
Rai, Ganesha ;
Jadhav, Ajit ;
Peyser, Brian D. ;
Austin, Christopher P. ;
Martin, Scott E. ;
Simeonov, Anton ;
Ferrer, Marc ;
Staudt, Louis M. ;
Thomas, Craig J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (06) :2349-2354
[58]   Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma [J].
Grommes, Christian ;
Pastore, Alessandro ;
Palaskas, Nicolaos ;
Tang, Sarah S. ;
Campos, Carl ;
Schartz, Derrek ;
Codega, Paolo ;
Nichol, Donna ;
Clark, Owen ;
Hsieh, Wan-Ying ;
Rohle, Dan ;
Rosenblum, Marc ;
Viale, Agnes ;
Tabar, Viviane S. ;
Brennan, Cameron W. ;
Gavrilovic, Igor T. ;
Kaley, Thomas J. ;
Nolan, Craig P. ;
Omuro, Antonio ;
Pentsova, Elena ;
Thomas, Alissa A. ;
Tsyvkin, Elina ;
Noy, Ariela ;
Palomba, M. Lia ;
Hamlin, Paul ;
Sauter, Craig S. ;
Moskowitz, Craig H. ;
Wolfe, Julia ;
Dogan, Ahmet ;
Won, Minhee ;
Glass, Jon ;
Peak, Scott ;
Lallana, Enrico C. ;
Hatzoglou, Vaios ;
Reiner, Anne S. ;
Gutin, Philip H. ;
Huse, Jason T. ;
Panageas, Katherine S. ;
Graeber, Thomas G. ;
Schultz, Nikolaus ;
DeAngelis, Lisa M. ;
Mellinghoff, Ingo K. .
CANCER DISCOVERY, 2017, 7 (09) :1018-1029
[59]   Developmental Acquisition of the Lyn-CD22-SHP-1 Inhibitory Pathway Promotes B Cell Tolerance [J].
Gross, Andrew J. ;
Lyandres, Julia R. ;
Panigrahi, Anil K. ;
Prak, Eline T. Luning ;
DeFranco, Anthony L. .
JOURNAL OF IMMUNOLOGY, 2009, 182 (09) :5382-5392
[60]   Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases [J].
Hadzidimitriou, Anastasia ;
Agathangelidis, Andreas ;
Darzentas, Nikos ;
Murray, Fiona ;
Delfau-Larue, Marie-Helene ;
Pedersen, Lone Bredo ;
Navarro Lopez, Alba ;
Dagklis, Antonis ;
Rombout, Paul ;
Beldjord, Kheira ;
Kolstad, Arne ;
Dreyling, Martin H. ;
Anagnostopoulos, Achilles ;
Tsaftaris, Athanasios ;
Mavragani-Tsipidou, Penelope ;
Rosenwald, Andreas ;
Ponzoni, Maurilio ;
Groenen, Patricia ;
Ghia, Paolo ;
Sander, Birgitta ;
Papadaki, Theodora ;
Campo, Elias ;
Geisler, Christian ;
Rosenquist, Richard ;
Davi, Frederic ;
Pott, Christiane ;
Stamatopoulos, Kostas .
BLOOD, 2011, 118 (11) :3088-3095